Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group

• FURUSE K.

収録刊行物

• J Clin Oncol

  J Clin Oncol 16 2126-2132, 1998

詳細情報

• CRID: 1573668924438586880
• NII論文ID: 10008354202
• NII書誌ID: AA10638385
• データソース種別:
  • CiNii Articles